Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis ; volume:10 ; number:1 ; day:13 ; month:7 ; year:2010 ; pages:1-9 ; date:12.2010
BMC infectious diseases ; 10, Heft 1 (13.7.2010), 1-9, 12.2010
- Urheber
-
Soares-Weiser, Karla
- Beteiligte Personen und Organisationen
-
Thomas, Sherine
G, Gail Thomson
Garner, Paul
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-10-207
- URN
-
urn:nbn:de:1111-2016030258084
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soares-Weiser, Karla
- Thomas, Sherine
- G, Gail Thomson
- Garner, Paul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21